CureMatch Articles & News
Oncologists need effective precision medicine tools to navigate the myriad of therapeutic options to best address each patient’s unique tumor profile. Described here is a digital solution, which analyzes tumor data (NGS, other), scores and ranks known and novel matching combinations of cancer drugs with molecular-level precision for decision support. All data was acquired through […]
CureMatch, Inc., a leader in precision digital medicine, announces that Razelle Kurzrock, MD, is presenting insights on groundbreaking artificial intelligence (AI) technology for individualized cancer treatment during the American Association for Cancer Research (AACR) all-virtual Annual Meeting 2021, Week 2, May 17-21, 2021. Board-certified medical oncologist, practicing physician and researcher, Dr. Kurzrock has led the […]
Santa Monica-based Quantgene Inc., which is developing a genetic testing technology that can detect cancer through a blood sample, has formed a partnership with San Diego-based cancer therapy guidance company CureMatch Inc. to improve treatments for cancer. The partnership announced March 24 will allow both companies to use their artificial intelligence technologies to provide more […]
Today, Dr. Razelle Kurzrock, CureMatch Co-Founder and Chief Medical Advisor, was recognized as Woman in Tech and a Woman of Influence by the San Diego Business Journal. Board-certified medical oncologist, practicing physician, researcher, and business leader, Dr. Kurzrock has led the evolution of the CureMatch Decision Support System that supports the doctor with therapeutic options […]
SANTA MONICA, Calif., March 24th, 2021 – Quantgene, Inc. and CureMatch, Inc. have announced a strategic partnership to combine genomic, cloud and AI technologies and improve precision treatments and long-term outcomes for patients diagnosed with cancer. Quantgene Liquid uses blood samples of cancer patients to help provide a systemic understanding of the mutational profiles of […]